News
  • Thomas Prevot

New Research Article shows Beneficial Effects of a New Drug in Transgenic Mouse Model with Cognitive Dysfunctions and Anxiety Phenotype
New Research Article shows Beneficial Effects of a New Drug in Transgenic Mouse Model with Cognitive Dysfunctions and Anxiety Phenotype 613 472 Thomas Prevot

The paper was published by Fee et al. in the International Journal of Neuropsychopharmacology. Patients suffering from mood and anxiety disorders often exhibit a deficit in brain inhibition. This deficit in brain inhibition is due do dysfunctional somatostatin (SST) cells, causing mood and cognitive symptoms in patients. Using transgenic mice in which the SST cell…

read more
  • Thomas Prevot

Alpha Cog graduates from the Creative Destructive Lab – Edition 2019-2020
Alpha Cog graduates from the Creative Destructive Lab – Edition 2019-2020 256 256 Thomas Prevot

Our team is proud of being part of the graduating ventures participating in the 2019-2020 Edition of the Creative Destruction Lab (CDL). CDL is a nonprofit organization that delivers an objectives-based program for massively scalable, seed-stage, science- and technology-based companies. Alpha Cog participated in the Health Stream, and received valuable inputs from mentors from September…

read more

CAMH Engage Breakthrough Challenge 2019 awarded to Dr. Thomas Prevot

CAMH Engage Breakthrough Challenge 2019 awarded to Dr. Thomas Prevot 1440 780 Etienne Sibille

On October the 18th, a sold-out crowd of nearly 300 young professionals gathered at Ricarda’s Toronto to award $10,000 as part of the 6th Annual Breakthrough Challenge, a signature event by CAMH Engage in support of mental health research. CAMH Engage is a group of young professionals in Toronto dedicated to reducing the stigma surrounding…

https://www.camh.ca/en/camh-news-and-stories/camh-engage-breakthrough-challenge-2019-awarded-to-dr-thomas-prevot

Lifting Brain Fog

Lifting Brain Fog 1920 800 Etienne Sibille

Effective treatments for cognitive dysfunction, such as declines in memory and other mental faculties often associated with depression or old age, may be within reach, according to Professor Etienne Sibille at the Centre for Addiction and Mental Health (CAMH) and the University of Toronto, Canada.

https://www.scientia.global/wp-content/uploads/Etienne_Sibille/Etienne_Sibille.pdf

Des pilules pour la mémoire?

Des pilules pour la mémoire? 150 150 Etienne Sibille

Des médicaments pourraient-ils permettre d’éviter les petites pertes de mémoire qui se multiplient fatalement, à mesure qu’on vieillit?

https://ici.radio-canada.ca/premiere/emissions/les-annees-lumiere/segments/reportage/107284/sante-science-memoire-cerveau-vieillissement-medicament
  • Etienne Sibille

New molecules reverse memory loss
New molecules reverse memory loss 1920 1280 Etienne Sibille

New therapeutic molecules developed at Toronto’s Centre for Addiction and Mental Health (CAMH) show promise in reversing the memory loss linked to depression and aging.

read more
  • Etienne Sibille

New drug raises hopes of reversing memory loss in old age
New drug raises hopes of reversing memory loss in old age 1880 400 Etienne Sibille

Dr. Sibille was interviewed by Ian Sample from The Guardian for his work on developing new therapeutics helping those with depression, schizophrenia and Alzheimer’s disease. Indeed, an experimental drug that bolsters ailing brain cells has raised hopes of a treatment for memory loss, poor decision making and other mental impairments that often strike in old…

read more

Senior Moment Stopper

Senior Moment Stopper 1920 800 Etienne Sibille

Scientists hope the daily pill will clear “brain fog”, and roll back mental aging by decades

https://www.thesun.co.uk/news/8430048/new-drug-could-end-senior-moments-by-reversing-memory-loss-in-old-age/
  • Etienne Sibille

New molecules reverse memory loss linked to Depression and Aging
New molecules reverse memory loss linked to Depression and Aging 150 150 Etienne Sibille

New therapeutic molecules developed at Toronto’s Centre for Addiction and Mental Health (CAMH) show promise in reversing the memory loss linked to depression and aging.

read more

New molecules reverse memory loss linked to depression, aging-CAMH

New molecules reverse memory loss linked to depression, aging-CAMH 150 150 Etienne Sibille

New therapeutic molecules developed at Toronto’s Centre for Addiction and Mental Health (CAMH) show promise in reversing the memory loss linked to depression and aging.

https://www.camh.ca/en/camh-news-and-stories/new-molecules-reverse-memory-loss-linked-to-depression-aging
  • 1
  • 2
Start Typing